Oklahoma Planning Grant for Clinical /Translational Scie

俄克拉荷马州临床/转化科学规划拨款

• 批准号: 7216101
• 负责人: John J. Mulvihill
• 金额: $ 21.87万
• 依托单位: UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-17 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7216101
• 关键词: NIH Roadmap Initiative tag; Native Americans; bioinformatics; clinical research; experimental designs; health science research; health science research support; interdisciplinary collaboration; sociology /anthropology; statistics /biometry; training

DESCRIPTION (provided by applicant): The University of Oklahoma Health Sciences Center (Oklahoma City and Tulsa), the University of Oklahoma Norman Campus, and the Oklahoma Medical Research Foundation are expanding their efforts in interdisciplinary clinical and translational science. Leveraged on our existing General Clinical Research Center (GCRC) used by all three partners, our objective in planning for a Clinical and Translational Science Award (CTSA) is to develop a comprehensive strategy to build clinical research infrastructure and training. With respect to national CTSA network, our local efforts will bring special strengths in Native American health research, medical anthropology, and practice-based research. Having completed an intense SWOT (Strengths, Weaknesses, Opportunities, and Threats) analysis, we seek planning funds to augment all nine suggested elements of a CTSA. The planning process will focus in particular on quantitative sciences, namely Design, Biostatistics, and Biomedical Informatics (DBBI), to demonstrate the feasibility of the larger CTSA enterprise. We have established a CTSA Executive Committee (four GCRC leaders), as well as an Advisory Council, including all eight Deans and the Provost of the Health Sciences Center, a clinical scientist from the Oklahoma Medical Research Foundation, an M.D./Ph.D. student, Directors of the OU Cancer Institute and the Oklahoma Diabetes Center, and an evaluator, who is Associate Vice-Provost for Faculty Development and Interdisciplinary Programs. Five individual and nationally prominent experts will visit for 1.5 days each to illustrate scientific success in clinical and translational science and to comment on our developments. CTS subcommittees on Curriculum and DBBI will be established to refine developments and launch expansion in those two crucial areas. Ph.D. and M.S. degrees in Clinical Investigation will be administered by the Graduate College and mentored by active clinical investigators. Ongoing qualitative and quantitative program evaluation will be conducted.

描述（由申请人提供）：俄克拉荷马大学健康科学中心（俄克拉荷马城和塔尔萨）、俄克拉荷马大学诺曼校区和俄克拉荷马医学研究基金会正在扩大其在跨学科临床和转化科学方面的努力。利用所有三个合作伙伴使用的现有普通临床研究中心 (GCRC)，我们规划临床和转化科学奖 (CTSA) 的目标是制定一项全面的战略来建设临床研究基础设施和培训。就国家 CTSA 网络而言，我们在当地的努力将在美洲原住民健康研究、医学人类学和基于实践的研究方面带来特殊优势。在完成密集的 SWOT（优势、劣势、机会和威胁）分析后，我们寻求规划资金来增强 CTSA 的所有九个建议要素。规划过程将特别关注定量科学，即设计、生物统计学和生物医学信息学 (DBBI)，以证明更大的 CTSA 企业的可行性。我们设立了 CTSA 执行委员会（四位 GCRC 领导人）以及咨询委员会，成员包括健康科学中心的所有八位院长和教务长、俄克拉荷马州医学研究基金会的临床科学家、医学博士/博士。学生、俄克拉荷马大学癌症研究所和俄克拉荷马州糖尿病中心主任以及评估员，负责教师发展和跨学科项目的副教务长。五位国内知名专家将每人访问 1.5 天，展示临床和转化科学方面的科学成功，并对我们的发展发表评论。 CTS 将成立课程和 DBBI 小组委员会，以完善这两个关键领域的开发并进行扩展。博士和硕士。临床研究学位将由研究生院管理，并由活跃的临床研究人员指导。 将进行持续的定性和定量计划评估。